Recognized by industry leaders for extensive coverage on African Asset Management
Abraaj and Proparco exit Tunisian pharma company to Blakeney and others
This product is currently unavailable.
Description
445
Abraaj and Proparco have exited 83% of their combined stake in Tunisian pharmaceutical company Unité de fabrication de medicaments to a consortium of investors including Washington-based SQM, Blakeney Asset Management, the Tunisian-Kuwaiti Consortium of Development (CTKD), and two local investors.
